Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Gene expression profile analysis of type 2 diabetic mouse liver.

Zhang F, Xu X, Zhang Y, Zhou B, He Z, Zhai Q.

PLoS One. 2013;8(3):e57766. doi: 10.1371/journal.pone.0057766. Epub 2013 Mar 1.

2.

Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.

Takamura T, Misu H, Matsuzawa-Nagata N, Sakurai M, Ota T, Shimizu A, Kurita S, Takeshita Y, Ando H, Honda M, Kaneko S.

Obesity (Silver Spring). 2008 Dec;16(12):2601-9. doi: 10.1038/oby.2008.419. Epub 2008 Oct 9.

3.

Gene expression profile change and associated physiological and pathological effects in mouse liver induced by fasting and refeeding.

Zhang F, Xu X, Zhou B, He Z, Zhai Q.

PLoS One. 2011;6(11):e27553. doi: 10.1371/journal.pone.0027553. Epub 2011 Nov 9.

4.

Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin.

Heishi M, Ichihara J, Teramoto R, Itakura Y, Hayashi K, Ishikawa H, Gomi H, Sakai J, Kanaoka M, Taiji M, Kimura T.

Diabetologia. 2006 Jul;49(7):1647-55. Epub 2006 May 23.

PMID:
16752183
5.

Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.

Suh YH, Kim Y, Bang JH, Choi KS, Lee JW, Kim WH, Oh TJ, An S, Jung MH.

J Mol Endocrinol. 2005 Apr;34(2):299-315.

PMID:
15821098
8.

Transcript profiling suggests that differential metabolic adaptation of mice to a high fat diet is associated with changes in liver to muscle lipid fluxes.

de Fourmestraux V, Neubauer H, Poussin C, Farmer P, Falquet L, Burcelin R, Delorenzi M, Thorens B.

J Biol Chem. 2004 Dec 3;279(49):50743-53. Epub 2004 Sep 17.

9.

Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis.

Colombo M, Gregersen S, Kruhoeffer M, Agger A, Xiao J, Jeppesen PB, Orntoft T, Ploug T, Galbo H, Hermansen K.

Metabolism. 2005 Dec;54(12):1571-81.

PMID:
16311088
10.

Gene expression profile in obesity and type 2 diabetes mellitus.

Das UN, Rao AA.

Lipids Health Dis. 2007 Dec 14;6:35.

11.

Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.

Aasum E, Cooper M, Severson DL, Larsen TS.

Can J Physiol Pharmacol. 2005 Feb;83(2):183-90.

PMID:
15791292
12.

Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.

Yamabe N, Noh JS, Park CH, Kang KS, Shibahara N, Tanaka T, Yokozawa T.

Eur J Pharmacol. 2010 Dec 1;648(1-3):179-87. doi: 10.1016/j.ejphar.2010.08.044. Epub 2010 Sep 15.

PMID:
20826139
13.

Microarray profiling of gene expression patterns in glomerular cells of astaxanthin-treated diabetic mice: a nutrigenomic approach.

Naito Y, Uchiyama K, Mizushima K, Kuroda M, Akagiri S, Takagi T, Handa O, Kokura S, Yoshida N, Ichikawa H, Takahashi J, Yoshikawa T.

Int J Mol Med. 2006 Oct;18(4):685-95.

PMID:
16964424
14.
15.

Epigallocatechin gallate supplementation alleviates diabetes in rodents.

Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, Weber P.

J Nutr. 2006 Oct;136(10):2512-8.

16.

Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.

Loffler M, Bilban M, Reimers M, Waldhäusl W, Stulnig TM.

J Pharmacol Exp Ther. 2006 Feb;316(2):797-804. Epub 2005 Oct 31.

17.

Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes.

Yang J, MacDougall ML, McDowell MT, Xi L, Wei R, Zavadoski WJ, Molloy MP, Baker JD, Kuhn M, Cabrera O, Treadway JL.

BMC Genomics. 2011 Jun 1;12:281. doi: 10.1186/1471-2164-12-281.

18.

Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.

Riu E, Ferre T, Mas A, Hidalgo A, Franckhauser S, Bosch F.

Biochem J. 2002 Dec 15;368(Pt 3):931-7.

19.

Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice.

Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ, Sung MK, Park YB, Lee MK.

Life Sci. 2006 Aug 15;79(12):1207-13. Epub 2006 Mar 27.

PMID:
16647724
20.

Bhlhe40, a potential diabetic modifier gene on Dbm1 locus, negatively controls myocyte fatty acid oxidation.

Takeshita S, Suzuki T, Kitayama S, Moritani M, Inoue H, Itakura M.

Genes Genet Syst. 2012;87(4):253-64.

Supplemental Content

Support Center